Conceptio
›
car-t-cells
Topic
car-t-cells
Knowledge-graph topic
· documents ABOUT car-t-cells across the archive
32
Documents about car-t-cells
Documents about car-t-cells
A Study of CAR-T Cells Targeting Autoimmune Diseases
#903265
ClinicalTrials.gov
CAR T-cells for the treatment of CNS malignancies.
#1001171
NCBI PubMed Central
CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma.
#843826
ClinicalTrials.gov
MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer
#1010230
ClinicalTrials.gov
Multidimensional Assessment of Quality of Life, Social and Professional Life and Care Utilization in Patients With Diffuse Large Cell B-cell Lymphoma Treated With CAR-T Cells
#148768
ClinicalTrials.gov
CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma
#865026
ClinicalTrials.gov
A Trial of "Armored" CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies
#992405
ClinicalTrials.gov
The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM
#642354
Europe PMC
BCMA-CS1 Compound CAR (cCAR) T Cells for Relapsed/Refractory Multiple Myeloma
#893354
ClinicalTrials.gov
CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies
#846096
ClinicalTrials.gov
Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases
#387166
ClinicalTrials.gov
Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T)
#897232
ClinicalTrials.gov
Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells
#982057
ClinicalTrials.gov
Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma
#895353
ClinicalTrials.gov
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma
#834525
ClinicalTrials.gov
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research
#855864
ClinicalTrials.gov
Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL
#875766
ClinicalTrials.gov
Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer
#898059
ClinicalTrials.gov
CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms
#967250
ClinicalTrials.gov
huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma
#905704
ClinicalTrials.gov
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's Syndrome
#805975
ClinicalTrials.gov
CAR T and PD-1 Knockout Engineered T Cells for Esophageal Cancer
#234414
ClinicalTrials.gov
IL13Rα2 CAR-T Cells Secreting Anti-PD-L1 Antibody for Recurrent Malignant Glioma
#181776
ClinicalTrials.gov
Engineering CAR-Vδ2 T cells to boost persistence and anti-tumor function
#183336
bioRxiv / medRxiv
The neurotoxic legacy of CAR-T cells: where do we stand?
#196050
NCBI PubMed Central
Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors
#234305
bioRxiv / medRxiv
CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid Leukemia
#356486
ClinicalTrials.gov
Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma
#888971
ClinicalTrials.gov
A Study of Armored CAR T Cells in People With Cancer
#896111
ClinicalTrials.gov
CD19-BCMA Dual Nanobody Based CAR-T Cells for Patients With DSA
#873668
ClinicalTrials.gov
Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
#885481
ClinicalTrials.gov
Transmembrane Domain Protein Effects on Chimeric Antigen Receptor T Cell Cytotoxic and Proliferation Capabilities
#308128
Harvard DASH
Preclinical advances and mechanistic insights of CAR-T therapy for acute myeloid leukemia: from target iteration to microenvironment regulation
#4573
Europe PMC
PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma
#18587
ClinicalTrials.gov
Modulation of the CD4 Ectodomain of HIV-Specific CAR T Cells to Enhance Efficacy
#273822
Harvard DASH
Immunotherapy With CD22 CAR T-cells for B-Cell Lymphoma, ALL and CLL
#481773
ClinicalTrials.gov
CAR-T cells microscopic and phenotypic identification in the peripheral blood
#670003
HAL (France)
Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus
#840068
ClinicalTrials.gov
An Exploratory Study by Fast CAR T Cells
#902043
ClinicalTrials.gov
HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma
#966497
ClinicalTrials.gov
Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma
#850644
ClinicalTrials.gov
Harnessing the NKG2D immune surveillance pathway using engineered T-cells for the treatment of human disease
#4654
Europe PMC
A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer
#851882
ClinicalTrials.gov
Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma
#854782
ClinicalTrials.gov
Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases
#1010625
ClinicalTrials.gov
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases
#853824
ClinicalTrials.gov
CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
#829817
ClinicalTrials.gov
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma
#876643
ClinicalTrials.gov
Engineered T cells achieve durable persistence in the brain by clearing a state-selective checkpoint that governs neuroimmune privilege
#651690
eScholarship
Temporal dynamics of immune effector cell‐associated haematotoxicity: Linking early and late cytopenias after chimeric antigen receptor T cells
#1000656
HAL (France)
← Previous
Page 2 of 6
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.